Actual Medicinal Product (AMP) -
Wezenla 130mg/26ml concentrate for solution for infusion vials (Amgen Ltd)
Name Details
|
Current Name
Wezenla 130mg/26ml concentrate for solution for infusion vials
|
Start Date
18-07-2024
|
End Date
|
|
|
Abbreviated Name
Wezenla 130mg/26ml concentrate for inf vials
|
Start Date
18-07-2024
|
|
Summary
- Licensed Route
- Intravenous
- Availability Restrictions
- None
- Licensing Authority
- Medicines - MHRA/EMA
- EMA Indicator
- EMA Monitoring
Codes
SNOMED Codes
|
Code
|
Start Date
|
End Date
|
| 43114811000001102 |
18-07-2024 |
|
Actual Medicinal Product Pack (AMPP) Information